News Column

Eden Research plc - Posting of Annual Report and Notice of AGM

June 10, 2014

ENP Newswire - 10 June 2014

Release date- 06062014 - Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, confirms that the Annual Report and Accounts for the year ended 31 December 2013, the Notice of the Annual General Meeting and a Form of Proxy were posted to shareholders on 4 June 2014.

The AGM is to be held at 12 noon on 26 June 2014 at The Four Pillars Hotel, Ducklington Lane, Witney OX28 4EX.

A copy of the 2013 Annual Report and Accounts and other documents are available on the Company's website.

Notice of AGM to be held on 26 June 2014

Proxy Form for 2014 AGM to be held on 26 June 2014


Eden Research plc

Clive Newitt

Managing Director

Tel: 01993 862 761

W H Ireland Limited

John Wakefield

Tel: 0117 945 3471

Walbrook PR Ltd

Paul McManus

Mob: 07980 541 893


Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

The Company has a number of patents and has a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of GBP12m in developing and protecting its intellectual property. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, identifying suitable industrial partners and entering into licence agreements.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: ENP Newswire

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters